Achilles Tendon Rupture - Intervention With Electrical Stimulation
Launched by KAROLINSKA UNIVERSITY HOSPITAL · Sep 15, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding a better way to help people heal after an acute Achilles tendon rupture, which is a common injury that can lead to complications like blood clots, muscle loss, and changes in tendon length. The researchers want to see if using a special treatment called calf neuromuscular electrical stimulation (C-NMES) during the time when the leg is in a cast or boot can help reduce these complications. They hope this will lead to better recovery and a quicker return to sports.
To participate in this trial, you need to be diagnosed with a recent Achilles tendon rupture within the last 10 days, and you should be between the ages of 16 and 75. Unfortunately, some people won’t be able to join, such as those who are pregnant or have certain medical conditions like heart failure or recent blood clotting issues. If you take part, you can expect to receive the C-NMES treatment while your leg is immobilized, and the team will monitor your recovery to see how well it works. The trial is currently not recruiting participants, but it aims to improve healing for those with this type of injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with acute unilateral Achilles tendon rupture
- • Included within 10 days after injury.
- Exclusion Criteria:
- • Inability to give consent to participate,
- • ongoing treatment with anticoagulants,
- • known allergy to contrast agents,
- • planned follow-up at another hospital,
- • inability to follow instructions,
- • known renal failure,
- • heart failure with pitting edema,
- • thrombophlebitis,
- • thromboembolic disease within the last 3 months,
- • previous surgery of the tendon,
- • known malignancy,
- • hemophilia,
- • pregnancy,
- • treatment with high doses of acetylsalicylic acid.
About Karolinska University Hospital
Karolinska University Hospital is a leading academic medical center in Sweden, renowned for its commitment to advanced healthcare research and innovative clinical practices. As a key sponsor of clinical trials, the hospital leverages its extensive expertise in medical research and collaboration with Karolinska Institutet, one of the world's foremost medical universities. The institution is dedicated to enhancing patient care through rigorous scientific investigation, focusing on a wide range of therapeutic areas. With a multidisciplinary approach and a strong emphasis on translational medicine, Karolinska University Hospital aims to bridge the gap between laboratory findings and clinical application, ultimately striving to improve health outcomes and advance medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Paul Ackermann, Prof,MD,PhD
Principal Investigator
Karolinska Institutet and Karolinska University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported